Cite
APA Citation
Balamurgan, R., Mohan, B., Kodgule, R., Tandon, M., Pendse, A., Khaladkar, K., Sharath, R., Katare, S., Suryawanshi, S., & Barkate, H. (2022). iDF21-0338 Results of Randomized Double Blind Phase III trial of FDC of Remogliflozin Etabonate and Teneligliptin in T2DM patients. Diabetes research and clinical practice, 186, . http://access.bl.uk/ark:/81055/vdc_100156441724.0x000038